medline.ch Onkologie Respirationstrakt

	Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a Phase I trial. Ann Oncol Schuler M, Berardi R, Lim WT, de Jonge M, Bauer TM, Azaro A, Gottfried M, Han JY, Lee DH, Wollner M, Hong DS, Vogel A, Delmonte A, Akimov M, Ghebremariam S, Cui X, Nwana N, Giovannini M, Kim TM. PMID: 32240796 [PubMed - as supplied by publisher]
	[NELSON trial 2020: Call for lung cancer CT screening of high-risk individuals]. Chirurg Hekmat K, Bruns CJ. PMID: 32240339 [PubMed - as supplied by publisher]
	Specific gut microbiome signature predicts the early-stage lung cancer. Gut Microbes Zheng Y, Fang Z, Xue Y, Zhang J, Zhu J, Gao R, Yao S, Ye Y, Wang S, Lin C, Chen S, Huang H, Hu L, Jiang GN, Qin H, Zhang P, Chen J, Ji H. PMID: 32240032 [PubMed - as supplied by publisher]
	The Efficacy and Safety of Low-frequency Rotating Static Magnetic Field Therapy Combined with Chemotherapy on Advanced Lung Cancer Patients: A Randomized, Double-blinded, Controlled Clinical Trial. Int J Radiat Biol Zhu M, Yang Z, Yu H, Zhu Q, Xu Y, Li Y, Li C, Zhao W, Liang Z, Chen L. PMID: 32238091 [PubMed - as supplied by publisher]
	Immune checkpoint inhibitors of the PD-1/PD-L1-axis in non-small cell lung cancer: promise, controversies and ambiguities in the novel treatment paradigm. Scand J Clin Lab Invest Breimer LH, Nousios P, Olsson L, Brunnström H. PMID: 32238062 [PubMed - as supplied by publisher]
	Determination of the target population in early benefit assessments in Germany: challenges for non-small-cell lung cancer. Eur J Health Econ Ten Thoren C, Balg C, Gibbert J, Mostardt S, Ripoll M, Schierbaum D, Schiller S, Schwalm A. PMID: 32236766 [PubMed - as supplied by publisher]
	Human Papillomavirus (HPV69/HPV73) Coinfection associated with Simultaneous Squamous Cell Carcinoma of the Anus and Presumed Lung Metastasis. Viruses Shea S, Muñoz M, Ward SC, Beasley MB, Gitman MR, Nowak MD, Houldsworth J, Sordillo EM, Ramirez JD, Paniz Mondolfi AE. PMID: 32235715 [PubMed - in process]
	Uncovering Prognosis-Related Genes and Pathways by Multi-Omics Analysis in Lung Cancer. Biomolecules Asada K, Kobayashi K, Joutard S, Tubaki M, Takahashi S, Takasawa K, Komatsu M, Kaneko S, Sese J, Hamamoto R. PMID: 32235589 [PubMed - in process]
	Impact of Bevacizumab Versus Erlotinib on Tumor Metrics in Patients With Previously Untreated Advanced Non-small Cell Lung Cancer: A Study by the Hellenic Cooperative Oncology Group. Anticancer Res Mountzios G, Mavropoulou X, Koliou GA, Linardou H, Samantas E, Kosmidis P, Fountzilas G, Charitandi A, Kalogera-Fountzila A. PMID: 32234902 [PubMed - in process]
	Real world experience of treatment and outcome in ALK-rearranged metastatic nonsmall cell lung cancer: A multicenter study from India. Curr Probl Cancer Patel A, Batra U, Prasad KT, Dabkara D, Ghosh J, Sharma M, Singh N, Suresh P, Jain P, Malik PS, Choudhary P, Ganguly S, Khurana S, Ms S, Bothra S, Muthu V, Biswas B. PMID: 32234264 [PubMed - as supplied by publisher]
	Tumor necrosis factor-related apoptosis-inducing ligand regulate the accumulation of extracelluar matrix in pulmonary artery by activating the phosphorylation of Smad2/3. Math Biosci Eng Yang E, Zhang XB, Chen QS, Ding CD. PMID: 32233583 [PubMed - in process]
	Validated LC-MS/MS method of Sphingosine 1-phosphate quantification in human serum for evaluation of response to radiotherapy in lung cancer. Thorac Cancer Tang X, Chen H, Chen G, Duan C, Fan Q, Li H, Wang Y, Li Z, Shi W, Liu Y. PMID: 32233070 [PubMed - as supplied by publisher]
	The Status of the EGFR T790M Mutation is associated with the Clinical Benefits of Osimertinib Treatment in Non-small Cell Lung Cancer Patients: A Meta-Analysis. J Cancer Zhao Z, Li L, Wang Z, Duan J, Bai H, Wang J. PMID: 32231715 [PubMed]
	SNP rs17079281 decreases lung cancer risk through creating an YY1-binding site to suppress DCBLD1 expression. Oncogene Wang Y, Ma R, Liu B, Kong J, Lin H, Yu X, Wang R, Li L, Gao M, Zhou B, Mohan M, Yu H, Hou Z, Shen H, Qian B. PMID: 32231272 [PubMed - as supplied by publisher]
	Biochemical Markers of Saliva in Lung Cancer: Diagnostic and Prognostic Perspectives. Diagnostics (Basel) Bel'skaya LV, Sarf EA, Kosenok VK, Gundyrev IA. PMID: 32230883 [PubMed]
	Phase II, open-label, multicenter trial of crizotinib in Japanese patients with advanced non-small cell lung cancer harboring a MET gene alteration: Co-MET study. Trials Shimokawa M, Nosaki K, Seto T, Ohashi K, Morise M, Horinouchi H, Sakakibara J, Murakami H, Yano S, Satouchi M, Matsumoto S, Goto K, Yoh K. PMID: 32228679 [PubMed - in process]
	Lung Cancer Prevention (PDQÂ®): Patient Version PDQ Screening and Prevention Editorial Board, PDQ Screening and Prevention Editorial Board. PMID: 26389497 [PubMed]
	Small Cell Lung Cancer Treatment (PDQÂ®): Health Professional Version PDQ Adult Treatment Editorial Board, PDQ Adult Treatment Editorial Board. PMID: 26389347 [PubMed]
	Propofol Improves Sensitivity of Lung Cancer Cells to Cisplatin and Its Mechanism. Med Sci Monit Huang Y, Lei L, Liu Y. PMID: 32225124 [PubMed - in process]
	Distribution, seasonal trends, and lung cancer risk of atmospheric polycyclic aromatic hydrocarbons in North China: A three-year case study in Dalian city. Ecotoxicol Environ Saf Hong WJ, Jia H, Yang M, Li YF. PMID: 32224369 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 106802

Seite 1 von 5341

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung